Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Novartis Targeting India For Natural Drug Ingredients

This article was originally published in PharmAsia News

Executive Summary

India is a prime target for Novartis, the Swiss drug maker looking for biodiverse resources from which to produce drugs. The outgoing chairman of Novartis India said the parent company is looking at the seas, rain forests, fungi and micro-organisms that use natural ingredients to protect themselves. Peter Jager said a Novartis project in China is looking at fungi that contain an ingredient that fights cancer, and at a micro-organism in Thailand that grows on an insect. But Jager said India itself has a great potential for bioresources and is part of the Novartis research plan. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts